not-yet-known not-yet-known not-yet-known unknown REFERENCES Spellberg B, Maertens J. Mucormycosis. Principles and Practice of Transplant Infectious Diseases. 2019:577-89. Serris A, Danion F, Lanternier F. Disease entities in mucormycosis. Journal of Fungi. 2019 Mar 14;5(1):23. Luo Z, Zhang L. Diagnosis and treatment of pulmonary mucormycosis: a case report. Experimental and therapeutic medicine. 2017 Oct 1;14(4):3788-91. Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clinical microbiology reviews. 2005 Jul;18(3):556-69. Mohammadi A, Mehdizadeh A, Ghasemi-Rad M, Habibpour H, Esmaeli A. Pulmonary mucormycosis in patients with diabetic ketoacidosis: a case report and review of literature. Tuberk Toraks. 2012 Jan 1;60(1):66-9. Cheruvattath, R., & Balan, V. (2007). Infections in Patients With End-stage Liver Disease. Journal of clinical gastroenterology , 41 (4), 403–411. Koshy, C. G., Shah, S., & Mammen, T. (2010). Subcutaneous emphysema of the chest: could it be pulmonary mucormycosis?. Thorax , 65 (3), 280. https://doi.org/10.1136/thx.2009.115659 Sturtevant JE, Latge JP. Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Immun. 1992; 60:1913–8. Ruping M, Heinz WJ, Kindo AJ, Rickerts V, Lass-Florl C, Beisel C, et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother. 2010; 65:296–302. Muqeetadnan M, Rahman A, Amer S, Nusrat S, Hassan S, Hashmi S. Pulmonary mucormycosis: an emerging infection. Case reports in pulmonology. 2012 Dec 12;2012. Kotoulas C, Psathakis K, Tsintiris K, Sampaziotis D, Karnesis L, Laoutidis G. Pulmonary mucormycosis presenting as Horner’s syndrome. Asian Cardiovascular and Thoracic Annals. 2006 Feb;14(1):86-7. Liu HC, Jan MS, Lin YC, Lin WL, Wu TC, Huang CN, Chen CM, Lu MC. A rare pulmonary zygomycosis manifested as chronic mediastinitis and bronchial perforation. European Respiratory Journal. 2011 Sep 1;38(3):734-5. Donado-Uña JR, Díaz-Hellín V, López-Encuentra A, Echave-Sustaeta JM. Persistent cavitations in pulmonary mucormycosis after apparently successful amphotericin B. European journal of cardio-thoracic surgery. 2002 May 1;21(5):940-2. Bansal M, Martin SR, Rudnicki SA, Hiatt KM, Mireles-Cabodevila E. A rapidly progressing Pancoast syndrome due to pulmonary mucormycosis: a case report. Journal of Medical Case Reports. 2011 Dec;5(1):1-4. McAdams HP, Rosado de Christenson M, Strollo DC, Patz Jr EF. Pulmonary mucormycosis: radiologic findings in 32 cases. AJR. American journal of roentgenology. 1997 Jun;168(6):1541-8. Yang Y, Fang B, Xu X, Fang F, Pan M, Zhong X, Sun T. Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China. Chin J Tuberc Respir Dis.  2013; 36:572–576. Yang C, Xie X. Diabetes and Nose-Cerebral Mucormycosis: A Case Study. Shiyong Yiyuan Linchuan Zachi.  2015; 12:183–184. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clinical Infectious Diseases. 2012 Feb 1;54(suppl_1):S55-60. Christin L, Wysong DR, Meshulam T, Hastey R, Simons ER, Diamond RD. Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun. 1998; 66:1181–9. Elsiesy H, Saad M, Shorman M, Amr S, Abaalkhail F, Hashim A, Al Hamoudi W, Al Sebayel M, Selim K. Invasive mucormycosis in a patient with liver cirrhosis: case report and review of the literature. Hepat Mon. 2013 Aug 11;13(8): e10858. doi: 10.5812/hepatmon.10858. PMID: 24171007; PMCID: PMC3810679. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41:634–53. Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An update. J Fungi. 2020;6(4):265